Traws Pharma, Inc. — Director's Dealing 2013

Jul 29, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-25

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-25	Stock Option (right to purchase)	$15	A	5000	Acquired	2023-07-25	Common Stock (5000)	Direct
2013-07-25	Stock Option (right to purchase)	$15	A	100000	Acquired	2023-07-25	Common Stock (100000)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 5,000 shares of Common Stock, is immediately exercisable and vests over 4 years from July 25, 2013, with 25% vesting on July 25, 2014 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.